Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00556361 · ClinicalTrials.gov registry record · Phase 2
Use of Ketamine Prior to Cardiopulmonary Bypass in Children
A Phase 2 study of Ventricular Septal Defect, sponsored by Arkansas Children's Hospital Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT00556361: Completed Phase 2 study of Ventricular Septal Defect, sponsored by Arkansas Children's Hospital Research Institute.
NCT00556361 is a Phase 2 study of Ventricular Septal Defect that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 24 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00556361, a Phase 2 study of Ventricular Septal Defect, has completed, sponsored by Arkansas Children's Hospital Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess whether the drug ketamine given prior to cardiopulmonary bypass can decrease injury to the cells in the brain.
Conditions Studied
Interventions
- DRUG ketamine
- DRUG saline
Study Locations (1)
Arkansas
- Arkansas Children's Hospital - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2004-07 |
| Est. Completion | 2007-11 |
| Phase | Phase 2 |
What the finished NCT00556361 record still lists
NCT00556361 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Ventricular Septal Defect appearing as the primary indexed condition, and to 2 interventions - of which ketamine is the first listed.
NCT00556361 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT00556361 about?
NCT00556361 is a clinical study titled "Use of Ketamine Prior to Cardiopulmonary Bypass in Children". To assess whether the drug ketamine given prior to cardiopulmonary bypass can decrease injury to the cells in the brain.
What is the current status of trial NCT00556361?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2004-07. Estimated completion is 2007-11.
What conditions does trial NCT00556361 study?
This clinical trial studies the following conditions: Ventricular Septal Defect.
What interventions are being tested in trial NCT00556361?
The interventions under investigation include: ketamine (DRUG), saline (DRUG).
Who is sponsoring clinical trial NCT00556361?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00556361 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00556361's enrollment target sits among peer trials
24 1756th of 2000 higher than 217 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia